Core Biomedicine
Funding reported, Series A, last update 3 weeks ago
Pharma biotech
Everything we hold on Core Biomedicine, newest first. Every line links to the filing or report it came from.
This profile is thin because we hold one source document on Core Biomedicine so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.
- 2026-07-29Headcount Not Stated Growing and expanding
Core Biomedicine Raises $21M Series A to Advance Precision Oncology Pipeline
Core Biomedicine raised $21M in Series A funding to advance its precision oncology pipeline in pharma and biotech, a stage where headcount goes into research and development. The announcement names no roles.
The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker